PubMed Health⌕ Search

Biomedical subjects

L I Bebawy

Publications and source records attributed to L I Bebawy.

10 recordsLinked to original sources
PubMed2003

Stability-indicating methods for the determination of sumatriptan succinate.

Four stability-indicating methods were developed for the determination of sumatriptan succinate in the presence of its degradation products. The first method depends on the quantitative densitometric evaluation of thin-layer chromatography of sumatriptan succinate in the presence of its degradation products without any interference. Cyclohexane-dichloromethane-diethylamine (50:40:10 v/v/v) was used as a mobile phase and the chromatogram was scanned at 228 nm. This method determines sumatriptan succinate in the concentration range l-8 microg per spot with mean percentage recovery 100.52+/-1.23%. The second and third methods depend on the use of first-derivative (D(1)) and second-derivative (D(2)) spectrophotometry at 234 and 238 nm, respectively. These methods determine the drug in the concentration range 1.25-10 microg x ml(-1) with mean percentage recovery 99.91+/-1.01% and 99.96+/-1.13% for (D(1)) and (D(2)), respectively. The fourth method depends on the use of ratio derivative spectrophotometric technique. The amplitude in the first derivative of the ratio spectra at 235 nm was selected to determine the cited drug in the presence of its degradation products. Calibration graph is linear in the concentration range 1.25-10 microg x ml(-1) with mean percentage recovery 100.19+/-1.19%. The suggested methods were successfully applied for determining sumatriptan succinate in bulk powder, laboratory-prepared mixtures and pharmaceutical dosage forms (Imigran tablet) with good accuracy and precision. The results obtained by applying the proposed methods were statistically analyzed and compared with those obtained by the reported method.

Calibration↗
PubMed2002

Stability-indicating methods for the determination of doxazosin mezylate and celecoxib.

Two stability-indicating methods were developed for the determination of doxazosin mesylate (I) and celecoxib (II) in the presence of their degradation products. The first method depends on the use of first derivative spectrophotometry (D(1)) at 256, 269 nm for (I) and (II), respectively. This method determines (I) and (II) in concentration ranges of 0.8-12 and 1-20 microg ml(-1) with mean percentage accuracies of 99.21+/-0.88 and 99.59+/-1.67% for (I) and (II), respectively. The second method depends on the quantitative densitometric evaluation of thin-layer chromatography of (I) and (II) in the presence of their degradation products without any interference. Methylisobutyl ketone-glacial acetic acid-water (20:10:10) was used as a mobile phase for (I) and cyclohexane-dichloromethane-diethyleamine (50:40:10) for (II). The chromatograms were scanned at 248 and 253 nm for (I) and (II), respectively. This method determines (I) and (II) in concentration ranges of l-4 microg per spot for both drugs with mean percentage accuracies of 100.19+/-0.95 and 99.91+/-1.95% for (I) and (II), respectively. The suggested methods were used to determine doxazosin mesylate and celecoxib in bulk powder, laboratory-prepared mixtures and pharmaceutical dosage forms (cardura tablet and celebrex capsule). The results obtained by applying the proposed methods were statistically analysed and compared with those obtained by the reported methods.

Adrenergic alpha-Antagonists↗
PubMed2001

Different methods for the determination of gestodene, and cyproterone acetate in raw material and dosage forms.

Four new precise accurate and selective methods have been developed for the determination of gestodene (I) and cyproterone acetate (II). The first method (A) depends on reaction of (I) and (II) with isoniazide in an acid medium and the colored products were measured at 378 and 400 nm, respectively. The second method (B) depends on the reaction of (I) and (II) with tetrazolium blue in an alkaline medium and the colored products were measured quantitatively at 515 and 520 nm, respectively. The optimum conditions for the analysis were studied. Both methods determined gestodene (I) in concentration range from 4 to 24 microg ml(-1) with mean percentage recoveries 99.54%+/-1.20 and 99.63%+/-1.89 for method A and B, respectively. For cyproterone acetate, the concentration ranges were 4-36 and 8-40 microg ml(-1) with mean percentage recoveries 99.94%+/-1.19 and 99.23%+/-2.00 for methods A and B, respectively. The third method (C) depends on the quantitative evaluation of (I) and (II) densitometrically using dichloroethane:methanol:water (95:5:0.2) as mobile phase and the chromatogram were scanned at 247 and 281 nm, respectively. Method (C) determines (I) and (II) in concentration ranges from 0.2 to 1.6 and 0.1-0.7 microg microl(-1) using Hamilton syringe 10 microl, with mean percentage recoveries 99.94%+/-1.19, and 99.82%+/-1.75, respectively. The fourth method (D) is a first derivative one depends on measuring the D(1) value at 303 nm for (II) only in concentration range 10-20 microg ml(-1) with mean percentage recoveries 99.95%+/-1.49.

Acne Vulgaris↗
PubMed1999

Determination of astemizole, terfenadine and flunarizine hydrochloride by ternary complex formation with eosin and lead(II).

A simple and sensitive spectrophotometric method has been established for the determination of astemizole(I), terfenadine(II) and flunarizine hydrochloride(III) based on ternary complex formation with eosin and lead(II). The method does not involve solvent extraction. The colour of the produced complex is measured at 547.5 nm for (I) and (III), while (II) is measured at 540.7 nm. Appropriate conditions were established for the colour reaction and for the eosin: Pb(II): drug ratio to obtain maximum sensitivity. Under the proposed conditions, the method is applicable over concentration range of 4.1-37.6, 11.8-47.2 and 2.4-19.1 microg x ml(-1) with mean percentage recovery of 99.20+/-0.63, 99.76+/-0.39 and 99.60+/-0.47% for (I), (II) and (III), respectively. The suggested method was applied for determination of (I), (II) and (III) in pharmaceutical preparations. Through the use of a non-ionic surfactant (methylcellulose), prior extraction of the drugs was unnecessary. The results obtained demonstrated that the method is equally accurate, precise and reproducible as the official or reported methods. For the purpose of enhancing the sensitivity, a fluorescence quenching method for determination of the studied drugs via ternary complex formation was also investigated. The detection limit for the studied drugs (I), (II) and (III) was 0.94-7.1 microg x ml(-1) with mean percentage recovery of 99.84+/-0.29, 99.24+/-0.36 and 99.34+/-0.26%, respectively. The results obtained by applying the proposed methods were statistically analyzed and compared with those obtained by official or reference methods. Unlike other reported ion-pair techniques, the suggested methods have the advantage of being applicable for the determination of the three drugs in their pharmaceutical dosage forms without prior extraction. They are recommended for quality control and routine analysis where time, cost effectiveness and high specificity of analytical techniques are of great importance.

Astemizole↗
PubMed1999

Simultaneous determination of some multicomponent dosage forms by quantitative thin layer chromatography densitometric method.

In this study, simultaneous determination of naproxen with diflunisal (mixture I), paracetamol with chlorzoxazone (mixture II) and chlorphenoxamine hydrochloride with 8-chlorotheophylline and caffeine (mixture III) in multicomponent mixtures was conducted by a thin layer chromatography densitometric method. The mobile phase ethyl acetate: methanol: ammonia 25% (85:15:5 v/v) was used for the separation of the components of mixtures (I) and (II) with Rf values of 0.16 for naproxen, 0.4 for diflunisal, 0.77 for paracetamol and 0.32 for chlorzoxazone. Efficient separation of the components of mixture (III) was attained using ethyl acetate as mobile phase with Rf values of 0.12, 0.62 and 0.42 for chlorphenoxamine hydrochloride, 8-chlorotheophylline and caffeine, respectively. Linearity ranges, mean recoveries and relative standard deviations in calibration graphs of the proposed method were calculated. The method has been successfully applied to pharmaceutical formulations, sugar-coated tablets, capsules and suppositories. The results obtained were statistically compared with those obtained by applying the reported alternate methods.

Acetaminophen↗
PubMed1999

Determination of some antihistaminic drugs by atomic absorption spectrometry and colorimetric methods.

Atomic absorption spectrometry (AAS) and colourimetric methods have been developed for the determination of pizotifen (I), ketotifen (II) and loratadine (III). The first method depends on the reaction of the three drugs (I); (II) and (III) with cobalt thiocyanate reagent at pH 2 to give ternary complexes. These complexes are readily extracted with organic solvent and estimated by indirect atomic absorption method via the determination of the cobalt content in the formed complex after extraction in 0.1 M hydrochloric acid. It was found that the three drugs can be determined in the concentration ranges from 10 to 74, 12 to 95 and 10 to 93 microg ml(-1) with mean percentage recovery of 99.71+/-0.87, 99.70+/-0.79 and 99.62+/-0.75%, respectively. The second method is based on the formation of orange red ion pairs as a result of the reaction between (I); (II) and (III) and molybdenum thiocyanate with maximum absorption at 469.5 nm in dichloromethane. Appropriate conditions were established for the colour reaction. Under the proposed conditions linearity was obeyed in the concentration ranges 3.5-25, 5-37.5 and 2.5-22.5 microg ml(-1) with mean percentage recovery of 99.60+/-0.41, 100.11+/-0.43 and 99.31+/-0.47% for (I): (II) and (III), respectively. The third method depends on the formation of radical ion using 2,3-dichloro-5,6-dicyano-p-benzoquinone (DDQ). The colour formed was measured at 588 nm for the three drugs (I); (II) and (III), respectively. The method is valid in concentration range 10-80 microg ml(-1) with mean percentage recovery 99.75+/-0.44, 99.94+/-0.72 and 99.17+/-0.36% for (I); (II) and (III), respectively. The proposed methods were applied to the analysis of pharmaceutical preparations. The results obtained were statistically analysed and compared with those obtained by applying the official and reference methods.

Cobalt↗
PubMed1999

Spectrophotometric determination of fluoxetine and sertraline using chloranil, 2, 3 dichloro-5, 6 dicyano benzoquinone and iodine.

Spectrophotometric procedures are presented for the determination of two commonly used antidepressant drugs, fluoxetine (I) and sertraline hydrochloride (II). The methods are based mainly on charge transfer complexation reaction of these drugs with either pi acceptors chloranil and 2, 3 dichloro-5, 6-dicyanoquinone (DDQ) or sigma acceptor iodine. The colored products are quantified spectrophotometrically at 550, 450 and 263 nm for fluoxetine and at 450, 455 and 290 nm for sertraline in chloranil, DDQ and iodine methods, respectively. The molar combining ratio and the optimum assay conditions were studied. The methods determine the cited drugs in concentration ranges of 8-640, 16-112 and 7.5-60 microg/ml with mean percentage recoveries of 99.83, 99.76 and 100.00% and R.S.D. of 1.24, 0.95 and 1.13% in fluoxetine and ranges of 16-160, 15-105 and 6-48 microg/ml with mean percentage recoveries of 100.39, 99.78 and 99.69% and R.S.D. of 1.02, 0.81 and 0.57% in sertraline for chloranil, DDQ and iodine methods, respectively. A more detailed investigation of the complex formed was made with respect to its composition, association constant K(AD)c, molar absorptivity xiAD(A) and free energy change deltaG. The proposed methods were applied successfully to the determination of the cited drugs either in pure or dosage forms with good accuracy and precision. The results were compared statistically with those given by the reported methods.

Antidepressive Agents↗
PubMed1997

Study of 7,7',8,8'-tetracyanoquinodimethane charge transfer complexes with some lone-pair-donating drugs.

The interaction between 7,7',8,8'-tetracyanoquinodimethane (TCNQ) and oxamniquine (I), azithromycin (II), omeprazole (III), pantoprazole (IV), and benzydamine hydrochloride (V) was investigated. The reaction conditions were optimized to obtain typical charge transfer complexes (CTC). The nature of the formed complexes was proved by thorough study of the thermodynamic parameters namely delta G (free energy), delta H (enthalpy), and delta S (entropy). The association constant KcAD and the molar absorptivity xi lambda AD of the formed complexes were determined using the Benesi-Hildbrand equation. The effect of temperature on these constants gave evidence of CTC formation. The reaction of TCNQ with I-V was found to be in 1:1; as being determined by the Foster method. Spectrophotometric measurements of the formed CTC were used for the quantitative determination of the studied drugs in both pure or pharmaceutical formulation. The mean percentage recoveries were 99.17 +/- 0.34, 99.75 +/- 0.12, 100.52 +/- 0.41, 98.75 +/- 0.63, and 99.23 +/- 62 for I, II, III, IV, and V, respectively. There was no significant difference observed when the method was statistically compared with the official and reference methods used to determine these drugs.

Anti-Inflammatory Agents, Non-Steroidal↗
PubMedDate not supplied

Stability-indicating methods for determining omeprazole and octylonium bromide in the presence of their degradation products.

Four stability-indicating assays were developed for determining omeprazole and octylonium bromide. Omeprazole is photodegraded and estimated in the presence of its degradation products sulphenamide (I) and benzimidazole sulphide (II) by 2 methods. The first method depends on use of first-, second-, and third-derivative spectrophotometry at 290.4, 320.6, and 311.6 nm, respectively. The second method is based on applying the charge-transfer technique with chloranil as pi acceptor to form a complex with omeprazole, the absorbance of which is measured at 377 nm. These methods determine omeprazole in concentration ranges of 5-20 micrograms/mL by first-, second-, and third-derivative spectrophotometry and 10-50 micrograms/mL by charge-transfer complexation with mean accuracies of 99.92 +/- 0.73, 99.71 +/- 1.02, 99.64 +/- 0.66, and 100.24 +/- 0.81%, respectively. Octylonium bromide is determined by a densitometric method using thin-layer chromatography in the presence of its degradation products p-[2-(n-octyoxy)benzoyl]-aminobenzoic acid (III) and diethyl-(2-hydroxyethyl)-methyl ammonium bromide (IV) without any interferences. Alternatively, octylonium bromide is evaluated by a colorimetric method using the acid dye rose bengal. The ion pair formed is extracted in chloroform at pH 4, and its absorbance is measured at 562 nm. These methods determine octylonium bromide in the presence of its degradation products in concentration ranges of 0.1-0.5 microgram/microL by densitometry and 4.5-22.5 micrograms/mL by colorimetry, with mean accuracies of 100.21 +/- 0.93 and 99.73 +/- 0.89%, respectively. The suggested methods were used to determine drugs in bulk powder, laboratory-prepared mixtures, and pharmaceutical dosage forms. Results were compared statistically with those obtained with reference methods.

Anti-Ulcer Agents↗